Replies to post #10129 on RespireRx Pharmaceuticals Inc (RSPI)

[Aiming4]

JD - it's worth noting that not everyone is underwater on COR here.

Based on the discussions on this board it has been possible to trade COR at some favorable times, in particular right after Dr. Stoll announced that Cortex believed the histo finding for CX717 that caused the clinical hold was due to an artifact.

There was a brief lull in that news sinking in to the rest of the world, but those who follow COR closely immediately knew what it meant and stocked up on COR at the $1.10 level.

The avg. price for the COR shares I hold is a bit above water, and I'm holding more now than I ever have.

There's a LOT of value and benefit to following a company closely, as long as one remains analytical about the stock.